What is AlphaGenome 2?
AlphaGenome 2 represents a cutting-edge AI research platform designed to investigate how DNA sequences influence gene regulation and related molecular processes. By entering specific DNA sequences, the framework can predict various molecular traits, thus aiding scientists in their exploration of gene expression patterns, regulatory functions, splicing, chromatin accessibility, and other genomic factors. Tailored for researchers aiming to unravel gene functionalities, the consequences of genetic variations, and disease biology, it serves both academic institutions and noncommercial research organizations. The platform is conveniently accessible through an online API, which offers developer tools that streamline the sequence submission process and facilitate the retrieval of predictions that are essential for computational studies. This empowers researchers to effectively prioritize their hypotheses and shape their upcoming experimental designs. It is essential to highlight that AlphaGenome 2 is exclusively intended for research purposes and has not been validated or authorized for any clinical or diagnostic applications, emphasizing the need for users to understand its intended use and limitations. This focus on research underscores the necessity of responsible practices in scientific exploration, ensuring that users remain cognizant of the framework's capabilities and constraints. Researchers utilizing this tool can significantly enhance their understanding of complex genomic interactions.
Pricing
Price Overview:
The AlphaGenome API is free of charge for noncommercial use. Commercial research access is in private preview.
Free Version:
Free Version available.
Integrations
Offers API?:
Yes, AlphaGenome 2 provides an API
No integrations listed.
Similar Software to AlphaGenome 2
AI Sales Representative - Your Future Sales Agent May Not Be Human at All
Transform your engaged website visitors into sales-ready leads without dedicating even a single working hour.
Using our cutting-edge WebID + Person identification technology, we target the most engaged visitors on your site, focusing on those who can provide the greatest value to your sales initiatives.
- Comprehensive Prospect Information: We collect 40 essential data points for each prospect, including their first name, last name, email address, and more.
- Engaged Yet Unidentified: These prospects are actively researching online but haven't yet interacted with your sales team.
- Key Position in the Sales Funnel: These visitors are well into your sales funnel, spending significant time on your crucial 'buying pages' while remaining anonymous, making them prime candidates for conversion into appointments.
- AI-Powered Engagement: Our AI Sales Rep adeptly identifies and engages these visitors, encouraging them to show interest in your offerings. This entire process is automated, allowing your sales team to focus solely on the leads that are most likely to convert—your accessible opportunities.
By harnessing AI, you can seamlessly convert your website visitors into leads that are ready for meetings, all while enhancing efficiency in your sales process.
Learn more about Visual Visitor
Dun & Bradstreet’s global data and analytics fuel AI-driven solutions for the credit-to-cash process. With D&B Finance Analytics, users benefit from an intuitive and adaptable platform that enables finance teams to enhance customer service, decrease expenses, and effectively manage risk. It empowers organizations to tackle credit and receivables risks, leading to reduced bad debts, lower Days Sales Outstanding (DSO), and improved cash flow. By streamlining manual decision-making, monitoring, customer interactions, and matching processes, businesses can operate more efficiently. Additionally, it provides customers with an online credit application and a payment portal that enhances the overall experience. The D&B Finance Analytics suite includes two key platforms: D&B Credit Intelligence and D&B® Receivables Intelligence, which work in tandem to deliver comprehensive insights and advanced technologies that drive success across all aspects of credit-to-cash operations. This integration allows users to swiftly identify credit risks, smoothly onboard new clients, and establish appropriate credit terms. Ultimately, these capabilities are designed to facilitate better financial management and foster growth.
Learn more about D&B Finance Analytics
Evo 2
Evo 2 is an advanced genomic foundation model that excels in predicting and creating tasks associated with DNA, RNA, and proteins. Utilizing a sophisticated deep learning architecture, it models biological sequences with precision down to single-nucleotide accuracy, demonstrating remarkable scalability in both computational and memory resources as context length expands. The model has been trained on an impressive 40 billion parameters and can handle a context length of 1 megabase, analyzing an immense dataset of over 9 trillion nucleotides derived from diverse eukaryotic and prokaryotic genomes. This extensive training enables Evo 2 to perform zero-shot function predictions across a range of biological types, including DNA, RNA, and proteins, while also generating novel sequences that adhere to plausible genomic frameworks. Its robust capabilities have been highlighted in applications such as the design of efficient CRISPR systems and the identification of potentially disease-causing mutations in human genes. Additionally, Evo 2 is accessible to the public via Arc's GitHub repository and is integrated into the NVIDIA BioNeMo framework, which significantly enhances its availability to researchers and developers. This integration not only broadens the model's reach but also represents a pivotal advancement in the fields of genomic modeling and analysis, paving the way for future innovations in biotechnology.
Learn more about Evo 2
AlphaGenome
AlphaGenome is an innovative API and Python toolkit crafted by Google DeepMind, specifically tailored for the realm of computational genomics. This powerful tool allows researchers to input DNA sequences or genetic variants to gain insights into various aspects such as gene expression, RNA splicing, chromatin accessibility, transcription-factor interactions, histone modifications, and genomic interactions. Additionally, it offers variant scoring and aids in the examination of genomic regions across both human and mouse datasets, enriched with tutorials and reference materials to support the development of programmatic workflows. By utilizing this resource, researchers can delve into how genetic changes impact gene regulation and effectively prioritize hypotheses for further exploration. Access is provided through a hosted API, along with a Python package for implementation on local systems, and numerous notebook examples to facilitate practical use. Although AlphaGenome proves to be a significant asset for research endeavors, it is crucial to understand that it has not undergone validation for clinical or diagnostic use, and its predictions should not be interpreted as clinical results. Furthermore, the platform fosters collaboration among scientists by creating an interactive environment that enhances data analysis, encouraging the sharing of insights and findings within the research community.
Learn more about AlphaGenome
Screenshots and Video
Company Facts
Company Name:
Google DeepMind
Date Founded:
2010
Company Location:
United Kingdom
Company Website:
deepmind.google/science/alphagenome/
Product Details
Deployment
SaaS
Training Options
Documentation Hub
Product Details
Target Company Sizes
Individual
1-10
11-50
51-200
201-500
501-1000
1001-5000
5001-10000
10001+
Target Organization Types
Mid Size Business
Small Business
Enterprise
Freelance
Nonprofit
Government
Startup
Supported Languages
English